Transplantation, AutologousBone Marrow TransplantationHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousBone Marrow PurgingCombined Modality TherapyMelphalanBone MarrowTransplantation ConditioningCyclophosphamideLymphoma, Non-HodgkinCarmustineWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsRemission InductionMultiple MyelomaPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseEtoposideBone Marrow CellsHodgkin DiseaseTreatment OutcomeCytarabineRecurrenceSalvage TherapyBusulfanDisease-Free SurvivalVincristineHematopoietic Stem CellsThiotepaStem CellsGraft SurvivalSurvival AnalysisSurvival RateLeukemia, Myeloid, AcutePodophyllotoxinLiver TransplantationLeukemiaHematologic NeoplasmsHematopoietic Stem Cell MobilizationRetrospective StudiesMyeloablative AgonistsFollow-Up StudiesLymphomaTransplantation ChimeraTime FactorsLeukemia, MyeloidPrognosisTissue DonorsDoxorubicinHematopoiesisLymphoma, FollicularPrednisonePrecursor Cell Lymphoblastic Leukemia-LymphomaGranulocyte Colony-Stimulating FactorColony-Forming Units AssayAntigens, CD34Antineoplastic Agents, AlkylatingDexamethasoneHistocompatibility TestingKidney TransplantationAnemia, AplasticActuarial AnalysisMyelodysplastic SyndromesMitoxantroneBone Marrow DiseasesAcute DiseaseNeoplasm, ResidualBone and BonesMesenchymal Stem Cell TransplantationLymphoma, Mantle-CellHistocompatibilityAmyloidosisAutograftsTransplantation, IsogeneicImmunosuppressive AgentsBoronic AcidsProspective StudiesAntibodies, MonoclonalPyrazinesDrug EvaluationLymphoma, B-CellAntineoplastic AgentsHepatic Veno-Occlusive DiseaseT-LymphocytesIfosfamideAntibodies, Monoclonal, Murine-DerivedNeuroblastomaCell TransplantationNeutropeniaCord Blood Stem Cell TransplantationImmunosuppressionLife TablesLeukocyte CountLymphoma, T-Cell, PeripheralThalidomideNeoplasms, Second PrimaryLeukapheresisLeukemia, Myelogenous, Chronic, BCR-ABL Positive